Science Current Events | Science News | Brightsurf.com
 

HIV treatment Current Events | HIV treatment News | 4

Sort By: Page Views | Date

FDA ignores critical information on home HIV tests
The FDA is ignoring critical information in deciding whether to approve an over-the-counter, rapid HIV test for home use.   view more (2009-05-29)

Study shows that many children of HIV-positive parents are not in their custody
A new joint study by UCLA and the Rand Corp. shows that more than half of children with an HIV-infected parent are not consistently in that parent's custody.   view more (2007-05-07)

AFRICAN HIV-1 EPIDEMIC NOT CAUSED BY MORE INFECTIOUS VIRAL SUBTYPE (p 1149)
The explosive HIV-1 epidemic in sub-Saharan Africa is unlikely to be the result of a viral subtype with increased infectivity, according to the results of a study published in this week’s issue of THE LANCET. The HIV-1 epidemic in eastern and southern sub-Saharan Africa is mainly caused by HIV-1 subtypes A, C, and D, whereas those in the USA... view more... (2001-04-11)

How breastfeeding affects HIV transmission
Mother to child transmission of HIV accounts for a large proportion of HIV infections in children, with many infected as a result of breastfeeding, which requires transfer of the virus across mucosal barriers.   view more (2005-10-21)

HIV's effect on white blood cells questioned by new research
Scientists have refuted a longstanding theory of how HIV slowly depletes the body's capacity to fight infection, in new research published today.   view more (2007-05-22)

Major step forward in effective treatment for HIV/AIDS
FROM PROCEEDINGS B OF THE ROYAL SOCIETY ONLINE ACCESS VIA FIRSTCITE FROM: 4 September 2002 New research findings by scientists in Germany* - soon to be published in The Royal Society`s Proceedings B journal - will be of major importance for HIV and AIDS treatment in the future. The findings provide estimates on the likely success of drugs which... view more... (2002-08-30)

Researchers induce HIV-neutralizing antibodies that recognize HIV-1 envelope protein, lipids
For the first time, researchers have experimentally induced antibodies that neutralize HIV-1 and simultaneously recognize both HIV-1 envelope protein and lipids.   view more (2009-09-02)

FURTHER STEPS TOWARDS A VACCINE AGAINST HIV
For white blood cells in the human body to be infected by the HIV virus, proteins in the virus must be allowed to interact with a number of different components on the surface of the white blood cell. Ideally anti-HIV preventive therapy or vaccines would prevent several of these interactions taking place and would, therefore, reduce the likelihood... view more... (1999-03-11)

Researchers uncover approach for possibly eradicating HIV infection
Researchers from the newly-established VGTI Florida and the University of Montreal have uncovered a possible method for eradicating HIV infection in the human body.   view more (2009-06-22)

ZAMBIAN WOMEN SUPPORT MASS NEVIRAPINE DISTRIBUTION (p 1611)
Pregnant women in Zambia-a country with high HIV-1 prevalence-would support a mass distribution campaign for the HIV drug nevirapine, according to a survey detailed in a research letter in this week's issue of THE LANCET.   view more (2001-11-07)

'POZ parties' signal potential to spread HIV 'superinfection'
The emergence of "POZ Parties"-parties exclusively for HIV positive men to meet other HIV positive men for sex-signals the potential to spread HIV "superinfection,"suggests research in Sexually Transmitted Infections.   view more (2005-09-29)

Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
A team of Harvard scientists has taken an important first step toward the development of new treatments to help people with HIV battle Mycobacterium tuberculosis (TB) infection.   view more (2009-07-01)

Tuberculosis Still a Risk for Patients Receiving HIV Drugs
People taking highly active antiretroviral therapy (HAART) for HIV infection remain susceptible to tuberculosis, though the risk is lower than for HIV-infected patients not on HAART.   view more (2005-11-14)

Should we test for HIV status in pregnant women?
Dr Lorraine Sherr, Professor Chris Hudson, and colleagues from several UK and European medical schools, have been studying the way other European countries are handling the problem, and found that the major variations between countries reflect the complexity of the ethics involved.   view more (1999-06-03)

Study finds major interruptions in antiretroviral therapy after release from prison
The vast majority of HIV-infected Texas prison inmates who receive antiretroviral therapy while incarcerated experience significant interruptions in HIV treatment after their release into the community.   view more (2009-02-25)

HIV Mortality in India Drops with Introduction of Generic Antiretroviral Therapy
The survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy (ART), according to an article in the Nov. 15 issue of Clinical Infectious Diseases, now available online.   view more (2005-10-20)

Herpes drug inhibits HIV in patients infected with both viruses
Researchers at the U.S. National Institutes of Health (NIH), McGill University and other institutions have discovered how a simple antiviral drug developed decades ago suppresses HIV in patients who are also infected with herpes.   view more (2008-09-16)

Rifampin kinetics poor in children
Rifampin (RMP), a first-line antituberculosis drug, reaches serum concentrations well below suggested lower limits when a standard dose of 8-12mg/kg body weight is given to children.   view more (2009-04-22)

Risk of fracture is significantly higher in HIV-infected patients
As antiviral treatment for HIV infection allows patients to live longer, many will be confronted with additional health challenges. A new study shows for the first time that one of these may be significantly increased risk of bone fractures.   view more (2008-08-29)

Antiretroviral Therapy Around Childbirth Reduces Risk Of Mother-To-Child HIV-1 Transmission (pp 1168, 1178)
Antiretroviral therapy given to women before, during, and after childbirth could be beneficial in reducing mother-to-child HIV-1 transmission in the first few weeks after delivery, suggest authors of a study in this week's issue of THE LANCET. However, this short-term benefit could be compromised unless new interventions are identified to prevent... view more... (2002-04-04)
Sort By: Page Views | Date
© 2009 BrightSurf.com